These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849 [TBL] [Abstract][Full Text] [Related]
23. Antiarrhythmic trials: a decade of growth. Kanjwal MY Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848 [No Abstract] [Full Text] [Related]
24. Amiodarone therapy in patients implanted with cardioverter-defibrillator for life-threatening ventricular arrhythmias. Satomi K; Kurita T; Takatsuki S; Yokoyama Y; Chinushi M; Tsuboi N; Nitta T; Shoda M; Mitamura H Circ J; 2006 Aug; 70(8):977-84. PubMed ID: 16864928 [TBL] [Abstract][Full Text] [Related]
25. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies. Dorian P; Newman D; Greene M Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382 [TBL] [Abstract][Full Text] [Related]
26. Implantable defibrillators in ischaemic cardiomyopathy: should women be treated differently to men? Leung DY Heart; 2014 Feb; 100(3):190-1. PubMed ID: 24270745 [No Abstract] [Full Text] [Related]
27. Controlling cardiac arrhythmias: an overview with a historical perspective. Singh BN Am J Cardiol; 1997 Oct; 80(8A):4G-15G. PubMed ID: 9354407 [TBL] [Abstract][Full Text] [Related]
31. Effect of beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins on mortality in patients with implantable cardioverter-defibrillators. Lai HM; Aronow WS; Kruger A; Desai H; Amin H; Frishman WH; Cohen M; Sorbera C Am J Cardiol; 2008 Jul; 102(1):77-8. PubMed ID: 18572039 [TBL] [Abstract][Full Text] [Related]
32. Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy. Droogan C; Patel C; Yan GX; Kowey PR Heart Fail Clin; 2011 Apr; 7(2):195-205, viii. PubMed ID: 21439498 [TBL] [Abstract][Full Text] [Related]
33. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
35. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180 [TBL] [Abstract][Full Text] [Related]
36. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study. Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114 [TBL] [Abstract][Full Text] [Related]
37. [Management of patients with sustained ventricular arrhythmia: anti-arrhythmia agents or defibrillator?]. Cappato R; Kuck KH Cardiologia; 1996 Feb; 41(2):95-105. PubMed ID: 8674097 [No Abstract] [Full Text] [Related]
38. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH; J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559 [TBL] [Abstract][Full Text] [Related]
39. A comparison of long-standing implantable cardioverter-defibrillator patients with and without appropriate therapy for ventricular arrhythmias: impact of a widening QRS. Dizon J; Chen K; Dizon S; Biviano A; Whang W; Ehlert F; Vazquez J; Nazif T; Garan H Europace; 2011 Jan; 13(1):77-81. PubMed ID: 21149513 [TBL] [Abstract][Full Text] [Related]